Many drug substances are intensely bitter or have other aversive taste challenges. When medicines are not properly taste-masked, patient adherence declines and outcomes suffer.
Palatability should never be the reason a medicine fails.
Senopsys combines deep expertise in taste assessment and taste masking to formulate palatable drug products. We collaborate with biopharmaceutical companies to create patient-accepted dosage forms of investigational and approved drugs for children and adults.
We use experienced human taste panels and a robust analytical toolkit to quantify taste challenges and guide formulation decisions, all conducted in compliance with Good Clinical Practice (GCP).
We apply a structured, sensory-directed development approach pioneered in the food industry to create palatable, patient-accepted formulations across liquids, powders, and solid dosage forms.
Senopsys is the taste-masking development partner of choice for 15 of the top 25 global pharma companies as well as dozens of emerging and mid-size pharma and biotech companies.
